Moreover, analysis of the GSE4290 dataset showed that levels of CAIX were higher in the GBM group than those in the astrocytoma (grades II and III) and non-tumor groups (Figure S1C). This evidence concerns the gene CA9 and astrocytoma (excluding glioblastoma).